Dr. Ali Al-Attar, MD

Dr. Al-Attar practices at Gastroenterology Associates of Northern Virginia, LLC in Alexandria, Virginia.

Dr. Al-Attar's NPI, 1659529907, was assigned on August 28, 2008. Dr. Al-Attar graduated from Georgetown University School of Medicine in 2004. Dr. Al-Attar holds Virginia license 0101249883.

Dr. Al-Attar's primary practice is Gastroenterology Associates of Northern Virginia, LLC, at 4660 Kenmore Ave, Alexandria, VA 22304 in Alexandria City. The practice phone is (703) 698-8960.

Dr. Al-Attar's primary practice is Gastroenterology Associates of Northern Virginia, LLC in Alexandria, Virginia. Dr. Al-Attar is also affiliated with Inova Alexandria Hospital. The medical group on file is Affiliates in Plastic Surgery. Dmand AI also links Dr. Al-Attar to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al-Attar practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic surgery is Dr. Al-Attar's primary specialty in the NPI Registry, under taxonomy code 208200000X. Dmand AI has Dr. Al-Attar's licenses on file in 4 states: Virginia, District of Columbia, Maryland and New York.

CMS data shows 74 Medicare services from Dr. Al-Attar across 4 procedure codes in 2024, all of them office visits, for 98 Medicare patients. Medicare paid $5,460 for them. Every service was in an office.

CMS counts 98 Medicare patients who saw Dr. Al-Attar in 2024. The largest group is 65 to 74, with 41 patients. 71% of them have high cholesterol, and 70% have high blood pressure. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Al-Attar's median patient age at 48, with 83% women.

In 2024, Dr. Al-Attar wrote 105 Medicare Part D claims for 35 patients. 96% of them were for generic drugs. CMS names the drug for 45 of them, across 3 drugs with 11 or more claims each, at $260 in total drug cost. In 2023, CMS named 29 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Al-Attar for performance year 2024, reported as part of a group. Dr. Al-Attar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of melanoma (skin cancer) excision by Dr. Al-Attar, more than 71% of the clinicians it reports for that procedure.

Mastectomy: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 53 general payments to Dr. Al-Attar from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 55% of the total. Lifecell Corporation paid the most, $2,665.

Dr. Al-Attar graduated from Georgetown University School of Medicine in 2004.